Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SOHO 2020 | Point-of-care CAR T-cells

Marcos de Lima • 26 Aug 2020
SOHO 2020
General CAR-T

Marcos de Lima, MD, UH Cleveland Medical Center, Cleveland, OH, discusses the significance of point-of-care CAR T-cell therapies. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Marcos de Lima

3:36
Results of a site-manufactured anti-CD19 CAR-T in nHL
Marcos de Lima • 31 Aug 2020
5:15
Outlook on the current CAR-T climate
Marcos de Lima • 1 Sep 2020
5:15
Outlook on the current CAR-T climate
Marcos de Lima • 27 Aug 2020
1:56
Are hypomethylating agents useful in preventing relapse in AML and MDS?
Marcos de Lima • 26 Oct 2019

Related Videos

4:07
Pooled fecal allogeneic microbiotherapy to treat refractory gastrointestinal acute GvHD
Florent Malard • 11 Apr 2024
5:23
Current and emerging treatment approaches for steroid-refractory acute & chronic GvHD
Mohamad Mohty • 17 Apr 2024
2:00
HHV-6 reactivation after haploidentical transplantation with PTCy & ATG: incidence and risk factors
Rémy Duléry • 15 Apr 2024
1:41
The consequences of regulatory changes on access to devices and reagents needed for graft processing
Christian Chabannon • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals